This new trial will be primarily focused on safety, but in addition it will involve a preliminary evaluation of the efficacy of combining Schwann cells with exercise and rehabilitation. They only have FDA approval to transplant a maximum of 10 people – remember that it is a Phase I safety trial.
Miami Project Schwann Trial for Chronic SCI Begins Enrollment for 10 people
Skip back to main navigation